A Study of LY2189265 and Sitagliptin in Participants With Type 2 Diabetes

NCT01408888 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

29

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus, Type 2

Interventions

BIOLOGICAL: LY2189265
DRUG: Sitagliptin

Sponsor

Eli Lilly and Company